From San Diego, at a meeting of the American Chemical Society
As a novel strategy to slow the progression of symptoms, researchers have designed polymer molecules that block the activity of proteins associated with Alzheimer’s disease.
These beta-amyloid proteins accumulate in the brains of people with Alzheimer’s. The substance’s toxicity triggers brain-cell death.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.